Humanitarian Assistance Program Sample Clauses
Humanitarian Assistance Program. Immune Design acknowledges IDRI has a global access strategy in association with various foundations and funders working in global health that, among other things, guides IDRI in developing affordable and accessible technology for the developing world (“Global Access Strategy Plan”). IDRI acknowledges that Immune Design has adopted a global access plan “IDC Global Access Plan”), attached hereto as Exhibit E, The intent of the IDC Global Access Plan is to demonstrate Immune Design’s intention to uphold and comply with the terms of the IDC Global Access Plan to the extent applicable to its activities under this Agreement and otherwise with respect to any and all Licensed Products and rights therein. At any time following approval of a Licensed Product in a ***, ***. Promptly following a request by IDRI, Immune Design or its sublicensee shall meet and discuss with IDRI the implementation of such programs and use commercially reasonable efforts to ***.
Humanitarian Assistance Program. Immune Design acknowledges IDRI has a global access strategy in association with various foundations and funders working in global health that, among other things, guides IDRI in developing affordable and accessible technology for the developing world. At any time following approval of a Licensed Product owned or Controlled by Immune Design in ***, IDRI may request that Immune Design use commercially reasonable efforts to institute commercially affordable and accessible humanitarian or patient assistance programs for the Licensed Product in ***. Promptly following a request by IDRI, Immune Design shall meet and discuss with IDRI the implementation of such programs and Immune Design shall use commercially reasonable efforts to implement commercially affordable and accessible humanitarian or patient assistance programs with respect to the Licensed Product in ***, taking into account, inter alia, that GLA or SLA may only be one component of a Licensed Product with other agents. Immune Design shall use commercially reasonable efforts to include an obligation materially consistent with this Section 3.4, on any sublicensee of the rights licensed to Immune Design under Article 2.